![]() |
|
|
A more recent version of this article appeared on December 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 8, 2005
Revised on August 31, 2005
Accepted on September 11, 2005
*The Lankenau Institute for Medical Research, Wynnewood, PA 19096;
Division of Gastroenterology, Lankenau Hospital, Wynnewood, PA 19096;
Department of Biology, St. Joseph’s University, Philadelphia, PA 19131;
Department of Biology, Villanova University, Villanova, PA 19085
Monitoring Editor: Asma Nusrat
Although ras mutations have been shown to affect epithelial architecture and polarity, their role in altering tight junctions remains unclear. Transfection of a valine-12 mutated ras construct into LLC-PK1 renal epithelia produces leakiness of tight junctions to certain types of solutes. Transepithelial permeability of D-mannitol increases sixfold but transepithelial electrical resistance increases over 40%. This indicates decreased paracellular permeability to Na+Cl-, yet increased permeability to nonelectrolytes. Permeability increases to D-mannitol (182 mw), polyethylene glycol (4000 mw) and 10,000 mw methylated dextran, but not 2000,000 mw methylated dextran. This implies a ceiling on the size of solutes that can cross a ras-mutated epithelial barrier, and therefore that the increased permeability is not due to loss of cells or junctions. While the abundance of claudin-2 declined to undetectable levels in the ras-overexpressing cells compared with vector controls, levels of occludin and claudins 1, 4, and 7 increased. The abundance of claudins 3 and 5 remained unchanged. An increase in ERK-2 phosphorylation suggests that the down-stream effects on the tight junction may be due to changes in the MAP kinase signaling pathway. These selective changes in permeability may influence tumorigenesis by the types of solutes now able to cross the epithelial barrier.
This article has been cited by other articles:
![]() |
N. Martin-Martin, G. Ryan, T. McMorrow, and M. P. Ryan Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression Am J Physiol Renal Physiol, March 1, 2010; 298(3): F672 - F682. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yanai, J.-A. Ko, N. Nomi, N. Morishige, T.-i. Chikama, A. Hattori, K. Hozumi, M. Nomizu, and T. Nishida Upregulation of ZO-1 in Cultured Human Corneal Epithelial Cells by a Peptide (PHSRN) Corresponding to the Second Cell-Binding Site of Fibronectin Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2757 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Brady, J. K. Alan, J. P. Madigan, A. S. Fanning, and A. D. Cox The Transforming Rho Family GTPase Wrch-1 Disrupts Epithelial Cell Tight Junctions and Epithelial Morphogenesis Mol. Cell. Biol., February 15, 2009; 29(4): 1035 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Flores-Benitez, R. Rincon-Heredia, L. F. Razgado, I. Larre, M. Cereijido, and R. G. Contreras Control of tight junctional sealing: roles of epidermal growth factor and prostaglandin E2 Am J Physiol Cell Physiol, January 1, 2009; 297(3): C611 - C620. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mima, M. Takehara, H. Takada, T. Nishimura, T. Hoshino, and T. Mizushima NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells Carcinogenesis, October 1, 2008; 29(10): 1994 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pollack, R. Sarkozi, Z. Banki, E. Feifel, S. Wehn, G. Gstraunthaler, H. Stoiber, G. Mayer, R. Montesano, F. Strutz, et al. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1714 - F1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Skrovanek, M. C. Valenzano, and J. M. Mullin Restriction of sulfur-containing amino acids alters claudin composition and improves tight junction barrier function Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1046 - R1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. U. Garcia, K. Urbanska, L. Koltowski, K. Reiss, and C. Sell Insulin-Like Growth Factor-I Produced by Seminal Vesicles: Relationship to Intraepithelial Basal Cell Hyperplasia in the Prostate Clin. Cancer Res., June 1, 2007; 13(11): 3140 - 3146. [Abstract] [Full Text] [PDF] |
||||